Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,805 | 140,596 | 127,746 | 120,175 | 18,204 |
| Marketable Securities | 191,799 | 94,681 | 5,862 | 6,160 | 9,556 |
| Receivables | 12,458 | 13,499 | 11,467 | 8,163 | 7,960 |
| Inventories | 2,536 | 2,650 | 2,005 | 1,718 | 801 |
| Other current assets | 46,849 | 46,526 | 96,250 | 96,250 | 0 |
| TOTAL | $301,932 | $299,954 | $244,737 | $233,543 | $37,334 |
| Non-Current Assets | |||||
| PPE Net | 428 | 478 | 509 | 619 | 671 |
| Investments And Advances | 0 | 0 | 0 | 337 | 0 |
| Intangibles | 162,472 | 163,933 | 169,187 | 170,771 | 95,201 |
| Other Non-Current Assets | 47,432 | 47,265 | 10,707 | 10,719 | 2,265 |
| TOTAL | $210,332 | $211,676 | $180,403 | $182,445 | $98,137 |
| Total Assets | $512,264 | $511,630 | $425,140 | $415,988 | $135,471 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,639 | 4,893 | 4,778 | 5,913 | 7,124 |
| Accrued Expenses | 23,820 | 22,318 | 20,328 | 19,347 | 27,883 |
| Other current liabilities | 55,522 | 49,216 | 97,460 | 68,214 | 32,046 |
| TOTAL | $86,981 | $101,947 | $172,382 | $102,165 | $107,539 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 40,804 | N/A |
| Other Non-Current Liabilities | 100,984 | 106,313 | 101,977 | 104,453 | 65,042 |
| TOTAL | $125,312 | $118,671 | $101,977 | $145,256 | $65,183 |
| Total Liabilities | $212,293 | $220,618 | $274,359 | $247,421 | $172,722 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,509 | 36,149 | 35,746 | 34,961 | 26,487 |
| Common Shares | 4 | 4 | 3 | 4 | 3 |
| Retained earnings | -65,153 | -62,684 | -168,262 | -142,734 | -179,175 |
| Other shareholders' equity | -682 | -102 | 760 | 1,087 | 4,070 |
| TOTAL | $299,971 | $291,012 | $150,781 | $168,567 | $-37,251 |
| Total Liabilities And Equity | $512,264 | $511,630 | $425,140 | $415,988 | $135,471 |